Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?

To: Mkilloran who wrote (6772)	1/21/1999 10:15:00 PM
From: BigKNY3	Respond to of 9523

MK: Thanks again for your contribution. We'll make you a PFEr yet!!! Here's how AP is reporting this story. BigKNY3 Brits To Pay for Limited Viagra Use 01/21/99 LONDON (AP) - In a reversal, Britain announced Thursday that Viagra would be made available to some patients through its national health system - but the plan was immediately criticized by doctors as being too restrictive. Health Secretary Frank Dobson proposed that the drug would be available to men whose impotence was due to pelvic surgery, spinal cord injury, removal of the prostate, diabetes, multiple sclerosis and certain genetic disorders. His plan was announced in a consultation document, which gives doctors and other interested parties six weeks to comment. "Impotence in itself is neither life-threatening nor does it cause physical pain," Dobson said. The National Health Service's current expenditure for treating impotence - $16.5 million - could increase by 10 times or more without some restrictions, he said. In September, Dobson had said that Viagra would not be available at all through the National Health Service. Dr. John Chisholm, chairman of the British Medical Association's General Practitioners Committee, called Dobson's plan "unfair and divisive." "These are cruel and ineffective distinctions between good and bad and acceptable and unacceptable causes of impotence," Chisholm said. "From the perspective of patients and doctors, this is a desperate condition." "This decision is quite bizarre," he added